Cite
HARVARD Citation
Sakaida, I. et al. (2017). Effectiveness and safety of tolvaptan in liver cirrhosis patients with edema: Interim results of post‐marketing surveillance of tolvaptan in liver cirrhosis (START study). Hepatology research. 47 (11), pp. 1137-1146. [Online].